Age, mean ± SD, years |
30.5 ± 5.6 |
30.3 ± 5.4 |
Weight before pregnancy, mean ± SD, kg |
65.2 ± 13.9 |
65.5 ±
14.8 |
Weight (last known), mean ± SD, kg |
77.6 ± 13.6 |
77.8 ±
13.7 |
Height, mean ± SD, cm |
165.8 ± 5.8 |
165.8 ± 6.5 |
Parity, N (%) |
|
|
Primiparous
|
113 (50.4%)
|
96 (45.1%)
|
Multiparous
|
111 (49.6%)
|
117 (54.9%)
|
Multiple pregnancy, N (%) |
25 (11.2%) |
24 (11.3%) |
Term, mean ± SD, weeks |
39.2 ± 1.9 |
38.9 ± 2.3 |
Prepartum Hb level, mean ± SD, g/dL |
11.8 ± 1.0 |
11.9 ±
0.9 |
Induction of labor, N (%) |
88 (39.3%) |
65 (30.5%) |
Instrumental vaginal delivery, N (%) |
54 (24.1%) |
43
(20.2%) |
Cause of PPH, N (%) |
|
|
Atony
|
179 (79.9%)
|
182 (85.4%)
|
Placenta retention
|
67 (29.9%)
|
52 (24.4%)
|
Lower genital tract wound
|
19 (8.5%)
|
19 (8.9%)
|
Other
|
8 (3.6%)
|
1 (0.5%)
|
Time from…, mean ± SD, min |
|
|
Delivery to start of bleeding
|
41.2 ± 57.4
|
38.5 ± 58.4
|
Delivery to start of sulprostone administration
|
73.8 ± 70.5
|
74.7 ± 116.5
|
Delivery to start of study drug infusion
|
92.0 ± 70.8
|
85.2 ± 65.9
|
Prior Tranexamic Acid |
|
|
N (%) |
107 (47.8%) |
102 (47.9%) |
Mean ± SD, g |
1.1 ± 0.3 |
1.1 ± 0.3 |
Estimated blood loss at the start of prostaglandin infusion, mean (SD),
mL |
896 ± 373 |
857 ± 315 |
Plasma Fibrinogen level at inclusion, mean ± SD, g/L |
4.2 ± 0.9 |
4.0 ±
1.0 |
N (%) |
|
|
≤ 2 g/L
|
2 (1.0%)
|
3 (1.5%)
|
]2; 3] g/L
|
19 (9.1%)
|
21 (10.8%)
|
]3-4] g/L
|
62 (29.7%)
|
75 (38.5%)
|
> 4 g/L
|
126 (60.3%)
|
96 (49.2%)
|